Dysregulation of the TSC-mTOR pathway in human disease
The mammalian target of rapamycin (mTOR) has a central role in the regulation of cell
growth. mTOR receives input from multiple signaling pathways, including growth factors and …
growth. mTOR receives input from multiple signaling pathways, including growth factors and …
Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome
MN Corradetti, K Inoki, N Bardeesy… - Genes & …, 2004 - genesdev.cshlp.org
Tuberous sclerosis complex (TSC) and Peutz-Jeghers syndrome (PJS) are dominantly inherited
benign tumor syndromes that share striking histopathological similarities. Here we show …
benign tumor syndromes that share striking histopathological similarities. Here we show …
TSC2: filling the GAP in the mTOR signaling pathway
The tumor-suppressor proteins TSC1 and TSC2 are associated with an autosomal dominant
disorder known as tuberous sclerosis complex (TSC). TSC1 and TSC2 function as a …
disorder known as tuberous sclerosis complex (TSC). TSC1 and TSC2 function as a …
[HTML][HTML] The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that plays an
essential role in cell growth control. mTOR stimulates cell growth by phosphorylating p70 …
essential role in cell growth control. mTOR stimulates cell growth by phosphorylating p70 …
Central-airway necrosis after stereotactic body-radiation therapy
MN Corradetti, AR Haas… - New England journal of …, 2012 - Mass Medical Soc
Central-Airway Necrosis after Stereotactic Body-Radiation Therapy | NEJM Skip to main content
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …
Radiogenomic analysis of locally advanced lung cancer based on CT imaging and intratreatment changes in cell-free DNA
The radiologic appearance of locally advanced lung cancer may be linked to molecular
changes of the disease during treatment, but characteristics of this phenomenon are poorly …
changes of the disease during treatment, but characteristics of this phenomenon are poorly …
Five-year long-term outcomes of stereotactic body radiation therapy for operable versus medically inoperable stage i non–small-cell lung cancer: analysis by …
…, MA Frick, EP Xanthopoulos, MN Corradetti… - Clinical Lung Cancer, 2019 - Elsevier
Background Stereotactic body radiation therapy (SBRT) is standard for medically inoperable
stage I non–small-cell lung cancer (NSCLC) and is emerging as a surgical alternative in …
stage I non–small-cell lung cancer (NSCLC) and is emerging as a surgical alternative in …
Serum antibodies to huntingtin interacting protein-1: a new blood test for prostate cancer
…, L Li, AJ Munaco, A Sreekumar, MN Corradetti… - Cancer research, 2005 - AACR
Huntingtin-interacting protein 1 (HIP1) is frequently overexpressed in prostate cancer. HIP1
is a clathrin-binding protein involved in growth factor receptor trafficking that transforms …
is a clathrin-binding protein involved in growth factor receptor trafficking that transforms …
[HTML][HTML] Dynamic simulation of motion effects in IMAT lung SBRT
Background Intensity modulated arc therapy (IMAT) has been widely adopted for Stereotactic
Body Radiotherapy (SBRT) for lung cancer. While treatment dose is optimized and …
Body Radiotherapy (SBRT) for lung cancer. While treatment dose is optimized and …
Brachial plexopathy in apical non-small cell lung cancer treated with definitive radiation: dosimetric analysis and clinical implications
MJ Eblan, MN Corradetti, JN Lukens… - International Journal of …, 2013 - Elsevier
PURPOSE: Data are limited on the clinical significance of brachial plexopathy in patients
with apical non-small cell lung cancers (NSCLC) treated with definitive radiation therapy. We …
with apical non-small cell lung cancers (NSCLC) treated with definitive radiation therapy. We …